Valeant Adds 3 Directors, Including a Pershing ExecutiveBy and
Investor Bill Ackman gets a board member at drugmaker
Other new members come from academia, pharmaceutical industry
Valeant Pharmaceuticals International Inc. will add three directors, including a representative from billionaire investor Bill Ackman’s investment firm, bolstering the board after facing criticism for its accounting and controversial distribution practices.
To continue reading this article you must be a Bloomberg Professional Service Subscriber.
If you believe that you may have received this message in error please let us know.